Linde A D Busweiler1, Marc H W A Wijnen2,3, Jim C H Wilde2,4, Egbert Sieders5, Sheila E J Terwisscha van Scheltinga6, L W Ernest van Heurn7, Joseph Ziros8, Roel Bakx2, Hugo A Heij2. 1. Pediatric Surgical Center of Amsterdam, Emma Children's Hospital-Academic Medical Center and VU Medical Center, P.O. Box 22660, 1100 DD, Amsterdam, The Netherlands. l.a.d.busweiler@lumc.nl. 2. Pediatric Surgical Center of Amsterdam, Emma Children's Hospital-Academic Medical Center and VU Medical Center, P.O. Box 22660, 1100 DD, Amsterdam, The Netherlands. 3. Department of Pediatric Surgery, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Department of Pediatric Surgery, University Hospital, Geneva, Switzerland. 5. Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands. 6. Department of Pediatric Surgery, Sophia Children's Hospital-Erasmus Medical Center, Rotterdam, The Netherlands. 7. Department of Pediatric Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. 8. Department of Pediatric Oncology, Emma Children's Hospital-Academic Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Achievement of complete surgical resection plays a key role in the successful treatment of children with hepatoblastoma. The aim of this study is to assess the surgical outcomes after partial liver resections for hepatoblastoma, focusing on postoperative complications, resection margins, 30-day mortality, and long-term survival. METHOD: Chart reviews were carried out on all patients treated for hepatoblastoma in the Netherlands between 1990 and 2013. RESULTS: A total of 103 patients were included, of whom 94 underwent surgery. Partial hepatectomy was performed in 76 patients and 18 patients received a liver transplant as a primary procedure. In 42 of 73 (58 %) patients, one or more complications were reported. In 3 patients, information regarding complications was not available. Hemorrhage necessitating blood transfusion occurred in 33 (45 %) patients and 9 (12 %) patients developed biliary complications, of whom 8 needed one or more additional surgical interventions. Overall, 5-year disease-specific survival was 82, 92 % in the group of patients who underwent partial hepatectomy, and 77 % in the group of patients who underwent liver transplantation. CONCLUSIONS: Partial hepatectomy after chemotherapy in children with hepatoblastoma offers good chances of survival. This type of major surgery is associated with a high rate of surgical complications (58 %), which is not detrimental to survival.
BACKGROUND: Achievement of complete surgical resection plays a key role in the successful treatment of children with hepatoblastoma. The aim of this study is to assess the surgical outcomes after partial liver resections for hepatoblastoma, focusing on postoperative complications, resection margins, 30-day mortality, and long-term survival. METHOD: Chart reviews were carried out on all patients treated for hepatoblastoma in the Netherlands between 1990 and 2013. RESULTS: A total of 103 patients were included, of whom 94 underwent surgery. Partial hepatectomy was performed in 76 patients and 18 patients received a liver transplant as a primary procedure. In 42 of 73 (58 %) patients, one or more complications were reported. In 3 patients, information regarding complications was not available. Hemorrhage necessitating blood transfusion occurred in 33 (45 %) patients and 9 (12 %) patients developed biliary complications, of whom 8 needed one or more additional surgical interventions. Overall, 5-year disease-specific survival was 82, 92 % in the group of patients who underwent partial hepatectomy, and 77 % in the group of patients who underwent liver transplantation. CONCLUSIONS: Partial hepatectomy after chemotherapy in children with hepatoblastoma offers good chances of survival. This type of major surgery is associated with a high rate of surgical complications (58 %), which is not detrimental to survival.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: M Semeraro; S Branchereau; R Maibach; J Zsiros; M Casanova; P Brock; C Domerg; D C Aronson; A Zimmermann; V Laithier; M Childs; D Roebuck; G Perilongo; P Czauderna; L Brugieres Journal: Eur J Cancer Date: 2012-11-09 Impact factor: 9.162
Authors: J Pritchard; J Brown; E Shafford; G Perilongo; P Brock; C Dicks-Mireaux; J Keeling; A Phillips; A Vos; J Plaschkes Journal: J Clin Oncol Date: 2000-11-15 Impact factor: 44.544
Authors: Hanna Lampela; Annukka Ritvanen; Silja Kosola; Antti Koivusalo; Risto Rintala; Hannu Jalanko; Mikko Pakarinen Journal: Scand J Gastroenterol Date: 2012-01 Impact factor: 2.423
Authors: J Marco Schnater; S Eleonore Köhler; Wouter H Lamers; Dietrich von Schweinitz; Daniël C Aronson Journal: Cancer Date: 2003-08-15 Impact factor: 6.860
Authors: Giorgio Perilongo; Rudolf Maibach; Elisabeth Shafford; Laurence Brugieres; Penelope Brock; Bruce Morland; Beatriz de Camargo; Jozsef Zsiros; Derek Roebuck; Arthur Zimmermann; Daniel Aronson; Margaret Childs; Eva Widing; Veronique Laithier; Jack Plaschkes; Jon Pritchard; Marcello Scopinaro; Gordon MacKinlay; Piotr Czauderna Journal: N Engl J Med Date: 2009-10-22 Impact factor: 91.245
Authors: J B Otte; J Pritchard; D C Aronson; J Brown; P Czauderna; R Maibach; G Perilongo; E Shafford; J Plaschkes Journal: Pediatr Blood Cancer Date: 2004-01 Impact factor: 3.167
Authors: Maartje A J van den Broek; Steven W M Olde Damink; Cornelis H C Dejong; Hauke Lang; Massimo Malagó; Rajiv Jalan; Fuat H Saner Journal: Liver Int Date: 2008-07 Impact factor: 5.828
Authors: Merel B Klunder; Janneke L M Bruggink; Leon D H Huynh; Frank A J A Bodewes; Alida F W van der Steeg; Kathelijne C J M Kraal; C P Kees van de Ven; Martine van Grotel; József Zsiros; Marc H W A Wijnen; I Q Quintus Molenaar; Robert J Porte; Vincent E de Meijer; Ruben H de Kleine Journal: Children (Basel) Date: 2022-04-07
Authors: Roberta Angelico; Chiara Grimaldi; Carlo Gazia; Maria Cristina Saffioti; Tommaso Maria Manzia; Aurora Castellano; Marco Spada Journal: Cancers (Basel) Date: 2019-10-31 Impact factor: 6.639
Authors: Kewei Li; Fanwen Jiang; Matthew Aizpuru; Ellen L Larson; Xiaolong Xie; Rongxing Zhou; Bo Xiang Journal: Medicine (Baltimore) Date: 2021-02-12 Impact factor: 1.817